David Rendall - Jun 18, 2021 Form 4 Insider Report for PURE BIOSCIENCE, INC. (PURE)

Role
Director
Signature
/s/ David Rendall
Stock symbol
PURE
Transactions as of
Jun 18, 2021
Transactions value $
$0
Form type
4
Date filed
6/24/2021, 07:36 PM
Previous filing
Jun 24, 2021
Next filing
Jul 19, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PURE Stock Option (Right to Buy) Award $0 +100K $0.00 100K Jun 18, 2021 Common Stock 100K $0.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.